SB225002 Induces Cell Death and Cell Cycle Arrest in Acute Lymphoblastic Leukemia Cells through the Activation of GLIPR1

Acute Lymphoblastic Leukemia (ALL) is the most frequent childhood malignancy. In the effort to find new anti-leukemic agents, we evaluated the small drug SB225002 (N-(2-hydroxy-4-nitrophenyl)-N’-(2-bromophenyl)urea). Although initially described as a selective antagonist of CXCR2, later studies have...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:PLoS One
Autori principali: de Vasconcellos, Jaíra Ferreira, Laranjeira, Angelo Brunelli Albertoni, Leal, Paulo C., Bhasin, Manoj K., Zenatti, Priscila Pini, Nunes, Ricardo J., Yunes, Rosendo A., Nowill, Alexandre E., Libermann, Towia A., Zerbini, Luiz Fernando, Yunes, José Andrés
Natura: Artigo
Lingua:Inglês
Pubblicazione: Public Library of Science 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4547718/
https://ncbi.nlm.nih.gov/pubmed/26302043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134783
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi